Compositions, methods and kits for treatment of cancer and autoimmune diseases
US9447160B2 · kind B2 · utility
0Cited by
4References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2013 |
| Grant date | Sep 20, 2016 |
| Priority date | — |
| Expiry date | Jan 18, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to fusion proteins having an IL-21 cytokine portion and an anti-CD20 antibody portion, and methods of using such fusion proteins. The invention also provides pharmaceutical compositions and kits utilizing the IL-21-anti-CD20 fusion proteins. In particular, the methods, kits and compositions of the invention are useful in the treatment of cancer and autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.